Psoriasis with concomitant psoriatic arthritis tied to an increased risk for endometriosisFebruary 23, 2022Psoriatic Arthritis
PsA: Secukinumab provides early and clinically meaningful improvements in patient-reported outcomesFebruary 23, 2022Psoriatic Arthritis
Rheumatology NewsPatients are interrupting DMARD use well into the COVID-19 pandemicFebruary 17, 2022COVID-19 UpdatesRheumatoid ArthritisPsoriatic ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsDietary recommendations for inflammatory rheumatic diseasesFebruary 10, 2022Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Rheumatology NewsGuselkumab controls axial involvement in PsA through 2 yearsFebruary 10, 2022Psoriatic Arthritis
Rheumatology NewsHow to make the most of your time with psoriasis patientsFebruary 9, 2022Psoriatic Arthritis
Rheumatology NewsFDA approves risankizumab (Skyrizi) for psoriatic arthritisJanuary 27, 2022Psoriatic Arthritis
Rheumatology NewsMore frequent secukinumab dosing found to benefit overweight psoriasis patientsJanuary 26, 2022Psoriatic ArthritisMixed Topics
Ultrasound variables could help identify psoriasis patients at risk of progressing to PsAJanuary 26, 2022Psoriatic Arthritis
Generally mild/moderate nonserious adverse events in PsA patients treated with tofacitinibJanuary 26, 2022Psoriatic Arthritis
Ultrasound evaluation of entheses helps discriminate psoriatic arthritis from fibromyalgiaJanuary 26, 2022Psoriatic Arthritis
Real-world efficacy and safety of apremilast in patients with psoriatic arthritisJanuary 26, 2022Psoriatic Arthritis
Younger age at psoriasis diagnosis or severe disease tied to delayed transition from psoriasis to PsAJanuary 26, 2022Psoriatic Arthritis
